Deputy Director Mu Kezhen and a delegation from the Provincial Department of Industry and Information Technology visited our company for a research visit.

Release date:

2020-09-18

Braving the sweltering heat of 35 degrees Celsius and battling the relentless heat waves, on the afternoon of July 23, a delegation of more than 10 members—including Mu Kezhen, Deputy Director of the Provincial Department of Industry and Information Technology; Ma Guang, Director of the Consumer Goods Division of the same department; and Zhang Yinghong, Director of the Pharmaceutical Division—visited our company to inspect and assess our production operations. Executive Vice President Wu Shaohui provided the visiting team with a detailed overview of our company’s development journey and current operational status, patiently answering their questions along the way. The delegation expressed admiration for our company’s steadfast commitment to advancing human health over the past decade, particularly in the fields of biochemical pharmaceuticals, with a strong focus on research, development, manufacturing, and sales of drugs targeting cardiovascular and cerebrovascular diseases, digestive disorders, cancer treatments, and neuropsychiatric conditions. Deputy Director Mu Kezhen emphasized the need to overcome the adverse effects of the pandemic, maintain unwavering confidence in growth, and accurately monitor emerging trends and developments within the industry. He urged companies to continuously strengthen technological upgrades and innovation efforts, thereby enhancing their core competitiveness. Meanwhile, all departments under the Provincial Department of Industry and Information Technology pledged to bolster their service mindset, proactively offering support by stepping up assistance in areas such as policies, technology, financing, and talent acquisition. These measures aim to create an optimal environment for enterprise growth, accelerate the implementation of supportive policies, and ensure the healthy and rapid development of businesses.

Braving the sweltering heat of 35 degrees Celsius and battling the relentless heat waves, more than 10 members—including Mu Kezhen, Deputy Director of the Provincial Department of Industry and Information Technology; Ma Guang, Director of the Consumer Goods Division of the same department; and Zhang Yinghong, Director of the Pharmaceutical Division—paid a visit to our company on the afternoon of July 23rd to inspect and assess our production operations.

Executive Vice President Wu Shaohui provided the research team with a detailed introduction to our company's development journey and current production operations, occasionally answering their questions along the way.

The research team expressed their appreciation for our company's longstanding commitment to advancing human health, its dedicated focus on biochemical pharmaceuticals, and its decade-long achievements in the R&D, production, and sales of cardiovascular, digestive, anti-cancer, and neuropsychiatric drugs.

Vice Director Mu Kezhen It was pointed out that to overcome the adverse effects of the pandemic, we must remain steadfast in our confidence for development, accurately grasp the new trends and developments emerging in the industry, and continuously strengthen enterprises' own technological upgrades and innovations—key steps to enhance their core competitiveness. Meanwhile, all departments within the Provincial Department of Industry and Information Technology will earnestly reinforce their service mindset, proactively offering support and taking initiative by providing robust assistance to businesses across various fronts, including policies, technology, funding, and talent. This comprehensive support will help create favorable conditions for enterprise growth, accelerate the effective implementation and refinement of relevant policies, and ultimately ensure the healthy and rapid development of businesses.

Vice Mayor Xu Hui, Deputy Secretary-General of the Municipal Government Chen Zhongliang, Director of the Municipal Bureau of Industry and Information Technology Zhu Yongku, and others accompanied the research visit.

Keywords:

Research, Enterprise, Development, Company, A Line, Production, Deputy Director-General, 10, Services

Enhance Party Spirit Cultivation, Innovate Teaching Models

The Provincial Drug Administration held a symposium at our company to support the development of enterprises specializing in "two products and one medical device."